Elliptic Laboratories AS (ELABS) — Capital Reinvestment Ratio
Latest as of December 2025:
4.85x
Elliptic Laboratories AS (ELABS) has a Capital Reinvestment Ratio of 4.85x as of December 2025, meaning it reinvests 5% of its operating cash flow (Nkr5.99 Million) in capital expenditures (Nkr29.08 Million). See how much free cash does Elliptic Laboratories AS generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
4.85x
Capex / Operating Cash Flow
Operating Cash Flow
Nkr5.99 Million
NOK
Capital Expenditures
Nkr29.08 Million
NOK
Data as of
Dec 2025
Most recent filing
Elliptic Laboratories AS Capital Reinvestment Ratio (2025–2025)
This chart tracks Elliptic Laboratories AS's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Elliptic Laboratories AS (2025–2025)
Year-by-year Capital Reinvestment Ratio for Elliptic Laboratories AS from 2025 to 2025. For live market cap and broader valuation context, see ELABS market cap overview.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 4.85x | Nkr5.99 Million | Nkr29.08 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow